AsianScientist (Apr. 21, 2011) – Dr. Nan-Shan Chang (張南山) is one of the nine recipients of the 2011 Distinguished Scientist Award by the US-based Society for Experimental Biology and Medicine (SEBM), according to the official website of National Cheng Kung University (NCKU), where Dr. Chang serves as its Professor and Chair of the Institute of Molecular Medicine.
The SEBM Distinguished Scientist Award is given annually to SEBM members who have made seminal contributions to the biomedical field and SEBM.
Dr. Chang is the first Taiwanese to receive such an honor.
Since he joined the SEBM in 2006, Dr. Chang has received three highly recognized awards, the Breast Cancer Concept Award from the US Department of Defense (DoD) in 2008, the Neurofibromatosis Research Award from DoD in 2010, and the SEBM Award this year.
After receiving a Ph.D. degree in immunology from the Medical University of South Carolina in 1984, Dr. Chang joined the University of Massachusetts Medical Center as a junior faculty in 1987, and became a full-time faculty at the Guthrie Research Institute in Pennsylvania in 1989.
Dr. Chang is noted for his discovery of a tumor-suppressor WW domain-containing oxidoreductase (WWOX) in 2000. The WWOX gene plays a crucial role in controlling cancer progression, and mutated versions of this gene may lead to cancer initiation and proliferation.
The Society for Experimental Biology and Medicine is a scientific society that promotes investigation in the biomedical sciences mainly through publication of a peer-reviewed journal, Experimental Biology and Medicine. The Society also fosters the career development of students, physician-scientists and new investigators.
——
Source: National Cheng Kung University.
Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.
